• Mashup Score: 5

    Bloomberg connects decision makers to a dynamic network of data, people and ideas, delivering business and financial information, news and insights globally.

    Tweet Tweets with this article
    • 1/ Breaking news. Pfizer’s mRNA vaccine 95% effective in final analysis. 44,000 participants, 170 cases total, with only 8 in vaccinated. 9/10 severe cases in placebo arm. Severe fatigue after 2cd dose in 3.8% was only major side effect #Covid_19 https://t.co/i16sYl8XP0

  • Mashup Score: 10

    Bloomberg connects decision makers to a dynamic network of data, people and ideas, delivering business and financial information, news and insights globally.

    Tweet Tweets with this article
    • BREAKING: NEW DATA from Pfizer shows 8 vaccinated participants fell ill, while 162 cases were seen in the placebo group. 9 of 10 severe cases in the trial occurred in the placebo group. All reaffirms initial results and is very encouraging. https://t.co/HL4lUCxpq2

  • Mashup Score: 0

    Bloomberg connects decision makers to a dynamic network of data, people and ideas, delivering business and financial information, news and insights globally.

    Tweet Tweets with this article
    • Just this am: @pfizer #covid19 vaccine FINAL analysis: -95% effective (44k participants) -Protection across all ages/ethnicities -No significant safety (3.7% severe fatigue after 2nd dose) -9 out of 10 severe cases in placebo group https://t.co/LVSJ9hMLjd @VincentRK @KizzyPhD https://t.co/Ry6aLHgOvT

  • Mashup Score: 2

    Bloomberg connects decision makers to a dynamic network of data, people and ideas, delivering business and financial information, news and insights globally.

    Tweet Tweets with this article
    • Exciting !!! Pfizer’s 2 dose m-RNA vaccine 90% efficacious in early results. Protects 4 weeks from the first dose. No major safety issues. If this holds up, it could be the game changer we’ve been waiting for #COVID19 #vaccines ⁦@VincentRK⁩ https://t.co/Nh92sprWw3